Estimates Revisions Nykode Therapeutics OTC Markets
Stocks
VACBF
NO0010714785
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
18:35:30 11/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3542 USD | +10.24% |
|
-.--% | +127.42% |
| 08-28 | Nykode Therapeutics Raises NOK286 Million via Share Placement | MT |
| 08-27 | ABG Sundal Collier raises the target price for Nykode Therapeutics to 7.0 Norwegian kroner (4.5), reiterates buy | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- VACC Stock
- VACBF Stock
- Consensus Nykode Therapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
